Please assess the completion status of the following clinical trial:

Trial Title: Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients of both genders between 50 and 90 years old scheduled for an outpatient first eye cataract phacoemulsification with topical anesthesia.~* ASA classification I II and III~Exclusion Criteria:~* ASA classification IV (patients with a chronic or severe disease).~* Hypersensitivity to midazolam or benzodiazepines~* acute narrow-angle glaucoma~* untreated open-angle glaucoma~* Patients with any sort of psychiatric or neurological disorder~* Patients on anti-anxiety medication~* Patients who have demand-type pacemakers installed before 1999\* \*Note: These are the exclusions listed for liability purposes by Alpha-Stim. There are no FDA exclusions.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Alpha-Stim intervention (Type: ACTIVE_COMPARATOR): One hour Alpha-Stim intervention with sham midazolam
- Sham Alpha-Stim with midazolam (Type: SHAM_COMPARATOR): Sham Alpha-Stim intervention with real midazolam administration
- Placebo (Type: PLACEBO_COMPARATOR): No Alpha-Stim and only topical anesthetics

Based on this trial design, predict the completion outcome and termination type (if applicable).